The Journal of Rheumatology
S

HCQ in Patients With Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials

By The Journal of Rheumatology FEATURING Stephen J. Balevic
By The Journal of Rheumatology FEATURING Stephen J. Balevic
96 views
February 18, 2021
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
15:26
Cleveland Clinic Rheumatology and Immunology Series

The Facts About COVID-19 Delta Breakthrough Infection and Vaccine Bo…

Feat. L. Calabrese
01:58
Covid-19 Global Rheumatology Alliance

The COVID-19 Global Rheumatology Alliance: Collecting Evidence-Based…

Feat. P. Robinson, J. Yazdany
29:14
Cleveland Clinic Rheumatology

Cytokine Storm: Where Rheumatologists, Oncologists, and ID Meet

Feat. D. Fajgenbaum
14:51
ACR Convergence 2021 Coverage

Outcomes of COVID-19 Infection in Patients With Primary Systemic Vas…

Feat. S. Sattui Cortes
15:27
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

Treatment of RMD COVID-19 Patients: Are Anti-Rheumatic Drugs Proving…

Feat. L. Wise
07:43
Cleveland Clinic Rheumatology and Immunology Series

Cleveland Clinic ACR 2020 Updates on COVID-19: Has Tocilizumab Prove…

Feat. L. Calabrese
18:35
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

COVID-19 in RMD Patients: What Are the Risk Factors for Severe COVID…

Feat. L. Wise
29:06
Cleveland Clinic Rheumatology

Vaccines for IMIDS: State of the Art

Feat. C. Calabrese
51:16
Yale School of Medicine

COVID-19 and Rheumatic Diseases

Feat. V. Chowdhary
24:32
RheumNow

Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of …

Feat. J. Cush, R. Tate, Y. Yusof, B. Mehta, O. Petryna
19:39
Cleveland Clinic Rheumatology

Principles of Managing COVID-19 in High Risk Outpatients

Feat. C. Calabrese
22:24
Cleveland Clinic Rheumatology

JAK Inhibitors in the COVID-19 Era: Assessing the Risks and Benefit

Feat. K. Winthrop
05:35
The Journal of Rheumatology

Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection…

Feat. J. Curtis
22:39
The Journal of Rheumatology

The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment

Feat. E. Silverman, J. Rosenbaum, J. Reveille, K. Winthrop
20:38
Cleveland Clinic Rheumatology

COVID-19 and the Risks From Immunomodulatory Therapies

Feat. Z. Wallace
10:00
RheumNow

RheumNow Updates on Pemphigus Vulgaris, the Efficacy of JAK Inhibito…

Feat. J. Cush
05:29
RheumNow

Rheumatic Disease Patients with COVID-19: Is Timing Important for Bi…

Feat. J. Cush
26:25
Cleveland Clinic Rheumatology

Hyperinflammation and Immunomodulatory Drugs Trials in COVID-19

Feat. P. Mehta
14:08
Cleveland Clinic Rheumatology

Managing COVID-19 in Immune-Mediated Inflammatory Disease Patients: …

Feat. C. Calabrese, L. Calabrese, P. Mehta
26:24
Hospital for Special Surgery

COVID-19 in Rheumatology Patients: What Are the Risks and Side Effec…

Feat. S. Sattui Cortes, R. Mackenzie